NDC11 57483028002
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 57483-0280-02 | 57483-0280 |
| 57483-0280-2 | 57483-0280 |
| 57483-280-02 | 57483-280 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Crcle Guaifenesin Extended-Release Tablets, 600 mg | GUAIFENESIN EXTENDED-RELEASE | Innovus Pharmaceuticals, Inc. | bba4b91a-bea9-41be-9588-5fb1483c7d10 | 2023-04-08 | Warnings | 57483-280-02 57483-280 57483028002 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.